Management tracks: Immunomedics, argenx

Antibody company Immunomedics Inc. (NASDAQ:IMMU) hired Robert Iannone as CMO and head of R&D. He was SVP and head of immuno-oncology, global medicines development at AstraZeneca plc (LSE:AZN; NYSE:AZN).

Antibody company argenx S.E. (Euronext:ARGX; NASDAQ:ARGX) hired

Read the full 356 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE